HTGM实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (15 Jun 2023 @ 04:00):

Stats
今日成交量	725 429
平均成交量	253 915
市值	1.06M
EPS	$0 ( 2024-03-28 )
下一个收益日期	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0281
ATR14	$0.314 (65.42%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Barat Stephen	Sell	888	Common Stock
2023-03-31	Barat Stephen	Sell	52	Common Stock
2023-02-02	Barat Stephen	Sell	0	Common Stock
2023-02-02	Barat Stephen	Sell	4 166	Stock Option (right to buy)
2023-02-02	Barat Stephen	Sell	2 083	Stock Option (right to buy)

INSIDER POWER
93.71
Last 98 transactions
Buy: 3 245 171 \| Sell: 16 674

音量相关性

長: 0.10 (neutral)

短: -0.53 (weak negative)

Signal:(18.674) Neutral

HTG Molecular Diagnostics 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

HTG Molecular Diagnostics 相关性 - 货币/商品

0.64
( weak )

0.73
( moderate )

0.00
( neutral )

0.75
( moderate )

-0.12
( neutral )

-0.75
( moderate negative )

HTG Molecular Diagnostics 财务报表

Annual	2022
营收:	$6.37M
毛利润:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2022
营收:	$6.37M
毛利润:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2021
营收:	$8.91M
毛利润:	$716 868 (8.05 %)
EPS:	$-0.206

FY	2020
营收:	$8.55M
毛利润:	$4.56M (53.31 %)
EPS:	$-0.376

Financial Reports:

No articles found.

HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.